These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25608936)

  • 1. A systems approach to drug discovery in Alzheimer's disease.
    Shelanski M; Shin W; Aubry S; Sims P; Alvarez MJ; Califano A
    Neurotherapeutics; 2015 Jan; 12(1):126-31. PubMed ID: 25608936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery, development and delivery in Alzheimer's disease.
    Brambilla D
    Pharm Res; 2017 Dec; 35(1):3. PubMed ID: 29288429
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease: new approaches to drug discovery.
    Bolognesi ML; Matera R; Minarini A; Rosini M; Melchiorre C
    Curr Opin Chem Biol; 2009 Jun; 13(3):303-8. PubMed ID: 19467915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.
    Brunden KR; Trojanowski JQ; Lee VM
    Nat Rev Drug Discov; 2009 Oct; 8(10):783-93. PubMed ID: 19794442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery.
    Ogishima S; Mizuno S; Kikuchi M; Miyashita A; Kuwano R; Tanaka H; Nakaya J
    Clin Pharmacol Ther; 2013 May; 93(5):399-401. PubMed ID: 23511713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2020 Mar; 15(3):269-271. PubMed ID: 31592694
    [No Abstract]   [Full Text] [Related]  

  • 7. Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) Knowledge Portal Aids Alzheimer's Drug Discovery through Open Data Sharing.
    Hodes RJ; Buckholtz N
    Expert Opin Ther Targets; 2016; 20(4):389-91. PubMed ID: 26853544
    [No Abstract]   [Full Text] [Related]  

  • 8. Can cloud-based tools accelerate Alzheimer's disease drug discovery?
    Cacabelos R; Teijido O; Carril JC
    Expert Opin Drug Discov; 2016; 11(3):215-23. PubMed ID: 26766514
    [No Abstract]   [Full Text] [Related]  

  • 9. An alternative approach to drug discovery for Alzheimer's disease dementia.
    Schubert D; Maher P
    Future Med Chem; 2012 Sep; 4(13):1681-8. PubMed ID: 22924506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to address the complexity of multi-targeted drug discovery for Alzheimer's disease?
    González JF; Sánchez-Montero JM
    Expert Opin Drug Discov; 2024 Oct; 19(10):1149-1152. PubMed ID: 39075884
    [No Abstract]   [Full Text] [Related]  

  • 11. How efficient are rodent models for Alzheimer's disease drug discovery?
    Guo B; Zhou Q
    Expert Opin Drug Discov; 2018 Feb; 13(2):113-115. PubMed ID: 29082769
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
    Pritchard JF
    BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S1. PubMed ID: 19090998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geroneuroprotectors: Effective Geroprotectors for the Brain.
    Schubert D; Currais A; Goldberg J; Finley K; Petrascheck M; Maher P
    Trends Pharmacol Sci; 2018 Dec; 39(12):1004-1007. PubMed ID: 30446211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considering a new paradigm for Alzheimer's disease research.
    Langley GR
    Drug Discov Today; 2014 Aug; 19(8):1114-24. PubMed ID: 24662035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and Future of Alzheimer's Therapy with the Best Approach.
    Singh H; Chawla V; Bala R; Dureja H
    CNS Neurol Disord Drug Targets; 2020; 19(9):691-697. PubMed ID: 32351189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic drugs for Alzheimer's disease.
    Peedicayil J
    Br J Clin Pharmacol; 2013 Apr; 75(4):1152-3. PubMed ID: 22905989
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural products as a rich source of tau-targeting drugs for Alzheimer's disease.
    Calcul L; Zhang B; Jinwal UK; Dickey CA; Baker BJ
    Future Med Chem; 2012 Sep; 4(13):1751-61. PubMed ID: 22924511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical Aspects of Alzheimer's Disease: Implications for Pharmaceutical Sciences : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
    Arosio P
    Pharm Res; 2017 Dec; 34(12):2628-2636. PubMed ID: 28963701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital technologies for cognitive assessment to accelerate drug development in Alzheimer's disease.
    Leurent C; Ehlers MD
    Clin Pharmacol Ther; 2015 Nov; 98(5):475-6. PubMed ID: 26272508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
    Storck SE; Pietrzik CU
    Pharm Res; 2017 Dec; 34(12):2637-2651. PubMed ID: 28948494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.